1. AstraZeneca pays Sobi $95M for priority review voucher — Amgen, Allergan biosimilar of Roche's blockbuster Rituxan clears another US pivotal study — Retrophin sinks as drug “Pharma Bro” Martin Shkreli co-invented fails — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Brad Herrmann: The LinkedIn Stalker

Discussion in 'Pinnacle Biologics' started by anonymous, Feb 20, 2016 at 11:09 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Since departing from PDT, Brad viewed my Linkedin profile on multiple occasions. Since Brad's departure from PDT, he appears to remain interested in where his former PDT specialists are working. Has he reached out to his former reps to reconnect? I'm certain his intentions are good, perhaps to network for opportunities.
     
  2. anonymous

    anonymous Guest

    Good ol' Brad. I haven't spoken to him in almost 4 years. I don't miss him. Although, I appreciate the opportunity he gave me with PDT. I hope he's well.